Citation Tools

0281: Phase I/Ii Dose-Escalation Trial of Patupilone Every 3 Weeks in Patients with Platinum-Resistant/Refractory Ovarian Cancer

Download to a citation manager

Cite this article as:
Huinink WWTB, Smit WM, Sufliarsky J, et al
0281: Phase I/Ii Dose-Escalation Trial of Patupilone Every 3 Weeks in Patients with Platinum-Resistant/Refractory Ovarian Cancer